Following the guidance issued by the NIHR (link below), we are pausing the PRED4 study until further notice.
Thank you for your understanding at this extremely difficult time, the Exeter team are available via email to answer any queries you may have.
nihr.ac.uk/news/dhsc-issues-…
... from 1st September 2019 as we now have enough recruits to the study we will be closing all arms except anti TNF induced skin reactions in IBD (ANTS) so please keep recruiting to ANTS! Thank you for your support 🧬😀
3000 patients 👩👩👦, 7 years 🗓️, 9 arms 🧬, 162 sites 🏥 later... thank you to all the patients, research nurses and PIs who have contributed to @pred4research....
Great, informative day for #exeterIBD at the #UKPGx2018 in London. Hearing the patients' perspectives on research was incredibly inspiring #personalisedmedicine
Well done and thank you to the brilliant research team at @IBDRoyalLondon for recruiting the first patient to our new study looking at anti-TNF induced adverse skin reactions in IBD (ANTS) #crohnsdisease #colitis
1
PRED4's 2 new substudies, ANTS (Anti-TNF induced adverse skin reactions in #IBD) & IMGEN (Immunogenicity to biologic drugs in IBD), are now open to recruitment #crohns #CrohnsDisease #Colitis
If you are at #ECCO2018 in Vienna this week, keep an eye out for some very interesting talks by our IBD Pharmacogenetics team covering @PANTSresearch genetic and clinical information and the PRED4 TIM study. We also have a poster on IBD surveillance, so lots to look out for!
Liver injury arm; ALT ULN is 35 for women and 40 for males. Min rise is 175 for women and 200 for males.
